MADISON - Stratatech is a Wisconsin company at the forefront of efforts to develop substitute skin. It's also a prime example of how emerging companies with innovative technology can compete for, and win, federal research grants that speed discoveries into the marketplace.
Madison-based Stratatech announced this week it has won a $4.6 million grant from the National Institutes of Health to begin clinical trials of ExpressGraft, a skin substitute designed to heal foot ulcers linked to diabetes. It works by closing the wounds and protecting them with a protein that fights infection.
To read the full, original article click on this link: Competitive federal grants help keep Wisconsin tech companies in the game (WTN News)
